This information is intended for members of the public in Ireland only
Home / Atrial Fibrillation

Atrial Fibrillation (AF)?

Reference information

This section contains reference information only, is general in nature and intended to provide a general overview of atrial fibrillation and venous thromboembolism for the general public in Ireland. It is not intended to replace in any way the opinion of a healthcare professional. For specific information about this pathology and/or detection, diagnosis, prognosis, administration and, where applicable, appropriate treatment for each specific case, please promptly consult a healthcare professional. The use of this website is subject to the legal notice, the privacy and cookie policy, and the applicable laws and regulations.

© 2015 Bristol-Myers Squibb Pharmaceuticals Limited

All corporate names and logos of BMS and/or of its products are trademarks of Bristol-Myers Squibb Company and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Pharmacovigilance Notice: This website has not been designed and must not be used to collect or provide safety information related to Bristol-Myers Squibb products. If your query relates to an adverse event experienced by a patient, please contact the Pharmacovigilance Department on 1 800 749 749 (Ireland only freephone number) or +44 1895 523740 (international number) which is available 24 hours a day, 365 days a year, or contact us by email at medical.information@bms.com.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

432IE1500021-11 / ELI/2015/010/1
Date of approval: September 2015